Bosnalijek is the largest industrial manufacturer of medicines in Bosnia and Herzegovina, established in 1951.
Our success is the result of deliberate strategy and joint efforts targeted at the company’s development.
Bosnalijek is the largest industrial manufacturer of medicines in Bosnia and Herzegovina, established in 1951.
Our success is the result of deliberate strategy and joint efforts for the Company’s development.
THE LEADING PHARMACEUTICAL COMPANY IN BOSNIA AND HERZEGOVINA
We are committed to meeting the expectations of our customers, shareholders and employees.
Investors
Bosnalijek d.d. is in the official quotation of the Sarajevo Stock Exchange (www.sase.ba) under ticker symbol BSNLR. We regularly rank among the top 5 most liquid stocks on the SASE and are classified in the SASX - 10 index. In this section of You can find more information on our business operations our web page.
BSNLR (BAM) KM
Average price: BAM
Change:
Best bid price: BAM
Best ask price: BAM
Volume:
Value: BAM
Number of transactions:
News
NOTICE/RECONVENING REGULAR ANNUAL ASSEMBLY
NOTICE ON RECONVENING THE REGULAR ANNUAL SHAREHOLDERS ASSEMBLY OF BOSNALIJEK JSC
In accordance with provisions of Article 233 Paragraph 2 to 4 of the current Law on Business Companies and Article 55 Paragraph 2 and 3 of the current Statute of Bosnalijek JSC and Decision No 3132/24 of 20 June 2024, the Supervisory Board of the company Bosnalijek JSC publishes:
NOTICE ON CONVENING THE REGULAR ANNUAL SHAREHOLDERS ASSEMBLY OF BOSNALIJEK JSC
In accordance with provisions of Article 230 Paragraph 1 of the current Law on Business Companies and Article 48 Paragraph 1 of the current Statute of Bosnalijek JSC and Decision No 2615/24 od 29 May 2024, the Supervisory Board of the company Bosnalijek JSC publishes:
In accordance with provisions of Article 233 Paragraph 2 to 4 of the current Law on Business Companies and Article 55 Paragraph 2 and 3 of the current Statute of Bosnalijek JSC and Decision No 3132/24 of 20 June 2024, the Supervisory Board of the company Bosnalijek JSC publishes: